Faramarz Alizadeh-Shabdiz, M.D
NPI 1790955052 · Otolaryngology Physician · Orange, CA
Enrolled with Medicare as Practitioner - Otolaryngology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1790955052
- Entity type
- Individual
- Primary specialty
- Otolaryngology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D
- Sex
- Male
- Sole proprietor
- No
- License
- A101653 (CA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,283 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 274 | $139 |
| Diagnostic Exam of Nasal Passages Using an Endoscope31231 | 262 | $211 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 212 | $179 |
| Diagnostic Exam of Voice Box Using a Flexible Endoscope31575 | 151 | $144 |
| Comprehensive Hearing and Speech Recognition Test92557 | 84 | $39 |
| Test for Eardrum and Muscle Function92550 | 83 | $23 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 11 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone Propionate | 140 | 79 |
| Azelastine Hcl | 116 | 67 |
| Cephalexin | 34 | 30 |
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 30 | 30 |
| Ciprofloxacin Hcl/Dexamethbrand: Ciprofloxacin-Dexamethasone | 29 | 26 |
| Methylprednisolone | 27 | 27 |
| Montelukast Sodium | 18 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$192 across 13 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-03-03
- Last updated
- 2011-09-13
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.